{"title":"Paper-based electrochemical aptasensor using Ti<sub>3</sub>C<sub>2</sub> MXene for sensitive detection of Mammaglobin-A biomarker.","authors":"Jaydeep Kanungo, Somya Sadaf, Dakshita Snud Sharma, Dharitri Rath, Chinmay Ghoroi","doi":"10.1016/j.talanta.2026.130421","DOIUrl":null,"url":null,"abstract":"<p><p>Breast cancer is one of the most prevalent cancers worldwide and a leading cause of cancer-related mortality. However, early detection of the disease can significantly reduce the mortality rate of cancer patients. The current detection methods of breast cancer are expensive, time consuming, invasive and require professional assistance. To overcome these challenges, a minimally invasive low-cost paper-based point-of-care (POC) electrochemical sensing platform has been developed for early-stage detection of breast cancer. The proposed sensor is fabricated using a screen-printing technique, incorporating two-dimensional Ti<sub>3</sub>C<sub>2</sub> (MXene) nanosheets onto the working electrode. These nanosheets provide enhanced electrochemical performance, enabling an exceptionally low limit of detection (LOD) ∼ 4 cells mL<sup>-1</sup>) attributed to their high conductivity and large surface area. The electrode surface is further functionalized with specific aptamers, facilitating selective target recognition. The proof-of-concept study was validated using multiple cell lines, including A549 (lung cancer cells), NIH3T3 (fibroblast), and HEK293 (kidney cells), and MDA-MB-231(breast cancer cell line), to evaluate the specificity of the developed aptasensor. The sensing mechanism relies on the selective binding of aptamers to Mammaglobin A proteins expressed on circulating tumor cells (CTCs). This interaction induces conformational changes in the aptamer, resulting in measurable alterations in the electrochemical properties at the electrode interface. The conjugation of the biomarker with the aptamer upon aptamer-protein interaction, results in a change in current, which is sensed by cyclic voltammogram (CV). The resulting signal is used to plot a calibration curve for quantitative analysis. Further, these sensing experiments are validated using in vitro experiments with human blood serum as a proof of concept. Overall, the developed paper-based electrochemical POC device offers significant advantages, including affordability, ease of use, rapid response, and quantitative detection capability.</p>","PeriodicalId":435,"journal":{"name":"Talanta","volume":"312 Pt A","pages":"130421"},"PeriodicalIF":6.7000,"publicationDate":"2027-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Talanta","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.1016/j.talanta.2026.130421","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Breast cancer is one of the most prevalent cancers worldwide and a leading cause of cancer-related mortality. However, early detection of the disease can significantly reduce the mortality rate of cancer patients. The current detection methods of breast cancer are expensive, time consuming, invasive and require professional assistance. To overcome these challenges, a minimally invasive low-cost paper-based point-of-care (POC) electrochemical sensing platform has been developed for early-stage detection of breast cancer. The proposed sensor is fabricated using a screen-printing technique, incorporating two-dimensional Ti3C2 (MXene) nanosheets onto the working electrode. These nanosheets provide enhanced electrochemical performance, enabling an exceptionally low limit of detection (LOD) ∼ 4 cells mL-1) attributed to their high conductivity and large surface area. The electrode surface is further functionalized with specific aptamers, facilitating selective target recognition. The proof-of-concept study was validated using multiple cell lines, including A549 (lung cancer cells), NIH3T3 (fibroblast), and HEK293 (kidney cells), and MDA-MB-231(breast cancer cell line), to evaluate the specificity of the developed aptasensor. The sensing mechanism relies on the selective binding of aptamers to Mammaglobin A proteins expressed on circulating tumor cells (CTCs). This interaction induces conformational changes in the aptamer, resulting in measurable alterations in the electrochemical properties at the electrode interface. The conjugation of the biomarker with the aptamer upon aptamer-protein interaction, results in a change in current, which is sensed by cyclic voltammogram (CV). The resulting signal is used to plot a calibration curve for quantitative analysis. Further, these sensing experiments are validated using in vitro experiments with human blood serum as a proof of concept. Overall, the developed paper-based electrochemical POC device offers significant advantages, including affordability, ease of use, rapid response, and quantitative detection capability.
期刊介绍:
Talanta provides a forum for the publication of original research papers, short communications, and critical reviews in all branches of pure and applied analytical chemistry. Papers are evaluated based on established guidelines, including the fundamental nature of the study, scientific novelty, substantial improvement or advantage over existing technology or methods, and demonstrated analytical applicability. Original research papers on fundamental studies, and on novel sensor and instrumentation developments, are encouraged. Novel or improved applications in areas such as clinical and biological chemistry, environmental analysis, geochemistry, materials science and engineering, and analytical platforms for omics development are welcome.
Analytical performance of methods should be determined, including interference and matrix effects, and methods should be validated by comparison with a standard method, or analysis of a certified reference material. Simple spiking recoveries may not be sufficient. The developed method should especially comprise information on selectivity, sensitivity, detection limits, accuracy, and reliability. However, applying official validation or robustness studies to a routine method or technique does not necessarily constitute novelty. Proper statistical treatment of the data should be provided. Relevant literature should be cited, including related publications by the authors, and authors should discuss how their proposed methodology compares with previously reported methods.